Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions

Autor: Christian J. Buchholz, Els Verhoeyen, Judit Szécsi, Rosybel Drury, Richard Schneider, Jean-Luc Coll, Stephen J. Russell, Irene Hartl, Bertrand Boson, Véronique Josserand, François-Loïc Cosset, Marie Pierre Grange
Přispěvatelé: Virologie humaine, École normale supérieure - Lyon (ENS Lyon)-IFR128-Institut National de la Santé et de la Recherche Médicale (INSERM), Groupe de Recherche Sur Le Cancer du Poumon : Bases Moléculaires de la Progression Tumorale, Dépistage et Thérapie Génique, Institut Albert Bonniot-Institut National de la Santé et de la Recherche Médicale (INSERM), Medizinische Biotechnologie, Paul-Ehrlich Institut, Mayo Clinic, École normale supérieure de Lyon (ENS de Lyon)-IFR128-Institut National de la Santé et de la Recherche Médicale (INSERM), Salas, Danielle
Jazyk: angličtina
Rok vydání: 2006
Předmět:
MESH: Matrix Metalloproteinases
MESH: Factor Xa
medicine.medical_treatment
Genetic enhancement
Cell
Hemagglutinin Glycoproteins
Influenza Virus

MESH: Amino Acid Sequence
Protein Engineering
Substrate Specificity
0302 clinical medicine
MESH: Genetic Vectors
Neoplasms
Drug Discovery
Chlorocebus aethiops
MESH: Animals
MESH: Neoplasms
0303 health sciences
MESH: Hemagglutinin Glycoproteins
Influenza Virus

Metalloendopeptidases
MESH: Leukemia Virus
Murine

Leukemia Virus
Murine

MESH: Protein Engineering
medicine.anatomical_structure
030220 oncology & carcinogenesis
Factor Xa
Molecular Medicine
Protein Binding
Proteases
MESH: Enzyme Activation
Genetic Vectors
Molecular Sequence Data
MESH: Metalloendopeptidases
[SDV.CAN]Life Sciences [q-bio]/Cancer
Gene delivery
Biology
Cleavage (embryo)
Cell Line
03 medical and health sciences
[SDV.CAN] Life Sciences [q-bio]/Cancer
Genetics
medicine
Animals
Humans
MESH: Protein Binding
Amino Acid Sequence
Molecular Biology
030304 developmental biology
Pharmacology
Protease
MESH: Molecular Sequence Data
MESH: Humans
Molecular biology
MESH: Cercopithecus aethiops
In vitro
Matrix Metalloproteinases
MESH: Cell Line
Enzyme Activation
Cell culture
MESH: Substrate Specificity
Zdroj: Molecular Therapy
Molecular Therapy, Cell Press, 2006, 14 (5), pp.735-44. ⟨10.1016/j.ymthe.2006.04.007⟩
Molecular Therapy, 2006, 14 (5), pp.735-44. ⟨10.1016/j.ymthe.2006.04.007⟩
ISSN: 1525-0016
1525-0024
DOI: 10.1016/j.ymthe.2006.04.007⟩
Popis: International audience; We report here a targeting method that exploits the expression pattern of cell surface proteases to induce gene delivery to specific tissues. We describe retroviral vectors harboring modified surface glycoproteins derived from an avian influenza virus hemagglutinin (HA) for which the cell entry properties, dependent on HA cleavage by producer cells, were conditionally blocked at a postbinding step by insertion of matrix metalloproteinase (MMP) substrates. We demonstrate that such vectors induce gene transfer, both in vitro and in mice harboring human tumor xenografts, only through contact with target cells expressing MMPs that cleave the substrate introduced into the recombinant HA. This selective gene transfer in MMP-rich cells was specifically inhibited by 1,10-phenanthroline, a broad-range MMP inhibitor. Importantly, such MMP-activatable vectors selectively transduced MMP-rich cells in heterogeneous populations containing MMP-rich and MMP-poor cells. These vectors will allow useful gene transfer applications into target cells exhibiting specific protease activities.
Databáze: OpenAIRE